Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

32
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
32
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.5K
Hepatitis01:25

Hepatitis

42
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
42
Types of Intermediate Filaments01:31

Types of Intermediate Filaments

5.2K
The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
5.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.1K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.1K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

28
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
28

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to "Acquired pseudoxanthoma elasticum progressing after chronic liver transplant rejection" by Tardieu et al. Ann Dermatol Venereol 2025;152:103416: Could anti-ABCC6 antibodies cause pseudoxanthoma elasticum after liver transplantation?

Annales de dermatologie et de venereologie·2025
Same author

Acrodermatitis continua of Hallopeau successfully treated with spesolimab.

Annales de dermatologie et de venereologie·2025
Same author

Methotrexate in monotherapy or combined with oral steroids for bullous pemphigoid in a real-life setting: A retrospective monocentric cohort.

Annales de dermatologie et de venereologie·2025
Same author

Quality of life of children with capillary malformations of the lower limbs: Evolution and associated factors. Data from the French national paediatric cohort, CONAPE.

Annales de dermatologie et de venereologie·2022
Same author

Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study.

Orphanet journal of rare diseases·2022
Same author

Dermatological and genetic data in tuberous sclerosis: A prospective single-center study of 38 patients.

Annales de dermatologie et de venereologie·2022
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Related Experiment Video

Updated: Apr 4, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K

[Type I interferonopathies].

J Munoz1, M Marque1, M Dandurand1

  • 1Département de dermatologie, hôpital Caremeau, CHRU de Nîmes, 4, rue du Professeur-Debré, 30029 Nîmes, France.

Annales De Dermatologie Et De Venereologie
|September 14, 2015
PubMed
Summary
This summary is machine-generated.

Type I interferonopathies are rare genetic disorders caused by increased type I interferons. Research is rapidly advancing understanding and targeted therapies for these inborn errors of immunity.

Keywords:
Aicardi-Goutières syndromeCANDLE syndromeChilblainsEngeluresFamilial chilblain lupusInterferonInterferonopathyInterféronInterféronopathieJASL syndromeJMP syndromeLupus érythémateux systémiqueLupus-engelure familialNakajo-Nishimura syndromePRAASProteasome-associated auto-inflammatory syndromesSAVISTINGSingleton-Merten syndromeSpondyloenchondrodysplasiaSpondyloenchondrodysplasieSyndrome CANDLESyndrome JASLSyndrome JMPSyndrome Nakajo-NishimuraSyndrome SAVISyndrome de Singleton-MertenSyndrome d’Aicardi-GoutièresSyndromes auto-inflammatoires liés au protéasomeSystemic lupus erythematosusVasculariteVasculitisVasculopathieVasculopathy

More Related Videos

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.7K
Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

20.5K

Related Experiment Videos

Last Updated: Apr 4, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.9K
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.7K
Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

20.5K

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Context:

  • Type I interferonopathies are a class of Mendelian disorders.
  • These conditions share a common pathophysiology involving the upregulation of type I interferons.
  • Known interferonopathies include Aicardi-Goutières syndrome, familial chilblain lupus, spondyenchondromatosis, PRoteasome-associated auto-inflammatory syndrome (PRAAS), and Singleton-Merten syndrome.

Purpose:

  • To summarize the current understanding of type I interferonopathies.
  • To highlight the phenotypic overlap, particularly cutaneous features like chilblain lupus.
  • To underscore the rapid evolution of this field with new disease and gene discoveries.

Summary:

  • Type I interferonopathies are characterized by the overproduction of type I interferons, leading to a spectrum of Mendelian disorders.
  • Phenotypic overlap is common, with early-onset cutaneous manifestations such as chilblain lupus being notable.
  • The field is dynamic, with ongoing identification of novel genes and diseases within this group of inborn errors of immunity.

Impact:

  • Advances in understanding type I interferon pathophysiology are enabling the development of targeted therapies.
  • Emerging treatments, including Janus-kinase and reverse transcriptase inhibitors, are under evaluation.
  • This research holds promise for improved management of these complex genetic immune disorders.